Skip to content
10-Q/A

Quarterly Report

Vidara Therapeutics International Public Ltd Co

0001193125-14-333391

← back to feed
Filed
Sep 5, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Capex Q2 2014 · Jun 30, 2014 $30.43K
Capex Q2 2014 · Jun 30, 2013 $396.94K
Cash And Equivalents Q2 2014 · Jun 30, 2014 $42.26M
Cash And Equivalents Q2 2014 · Dec 31, 2013 $30.28M
Cash And Equivalents Q2 2014 · Jun 30, 2013 $34.33M
Cash And Equivalents Q2 2014 · Dec 31, 2012 $23.52M
Stockholders Equity Q2 2014 · Jun 30, 2014 $71.12M
Stockholders Equity Q2 2014 · Dec 31, 2013 $55.12M
Current Liabilities Q2 2014 · Jun 30, 2014 $15.48M
Current Liabilities Q2 2014 · Dec 31, 2013 $16.15M
Total Liabilities Q2 2014 · Jun 30, 2014 $38.1M
Total Liabilities Q2 2014 · Dec 31, 2013 $39.89M
Current Assets Q2 2014 · Jun 30, 2014 $58.7M
Current Assets Q2 2014 · Dec 31, 2013 $41.91M
Total Assets Q2 2014 · Jun 30, 2014 $109.22M
Total Assets Q2 2014 · Dec 31, 2013 $95M
Sga Expense Q2 2014 · Jun 30, 2014 $3.01M
Sga Expense Q2 2014 · Jun 30, 2014 $6.13M
Sga Expense Q2 2014 · Jun 30, 2013 $1.96M
Sga Expense Q2 2014 · Jun 30, 2013 $3.29M
Net Income Q2 2014 · Jun 30, 2014 $9.19M
Net Income Q2 2014 · Jun 30, 2014 $15.69M
Net Income Q2 2014 · Jun 30, 2013 $5.89M
Net Income Q2 2014 · Jun 30, 2013 $10.09M
Operating Income Q2 2014 · Jun 30, 2014 $9.79M
Operating Income Q2 2014 · Jun 30, 2014 $16.95M
Operating Income Q2 2014 · Jun 30, 2013 $5.72M
Operating Income Q2 2014 · Jun 30, 2013 $10.13M
Gross Profit Q2 2014 · Jun 30, 2014 $17.59M
Gross Profit Q2 2014 · Jun 30, 2014 $34.09M
Gross Profit Q2 2014 · Jun 30, 2013 $11.78M
Gross Profit Q2 2014 · Jun 30, 2013 $22.69M
Cost Of Revenue Q2 2014 · Jun 30, 2014 $802.28K
Cost Of Revenue Q2 2014 · Jun 30, 2014 $1.66M
Cost Of Revenue Q2 2014 · Jun 30, 2013 $1.74M
Cost Of Revenue Q2 2014 · Jun 30, 2013 $3.24M
Long Term Debt Q2 2014 · Dec 31, 2013 $1.17M
Short Term Debt Q2 2014 · Dec 31, 2013 $617.1K